Clinical Diagnostics In Mexico: Market Analysis and Participant Directory

2012-03-01
Published : Mar-2012

The following sectors of the IVD market are covered in this report:

  • Routine Chemistry(Automated, Semi-automated Reagents)
  • Critcal Care Chemistry (Combination Blood Gases, ISE Electrolytes, Reagents )
  • Hematology(5 Part Diff Systems, 3 Part Diff Systems , Semi-auto Systems, Reagents)
  • Urinalysis
  • Coagulation
  • Immunology and Molecular Testing, including: (Blood Screening, Infectious Diseases, Hormones, Tumors, Proteins, Allergy, Neonatal, Prenatal. HbA1c, Other Molecular)

As part of its comprehensive coverage, the following market information is presented in this report:

  • Overview of the Diagnostics Industry in Mexico
  • Profiles of Key International Companies Operating in the market
  • Profiles of Mexican IVD Companies and Distributors – Who is Distributing What?
  • Current Market Size for IVD instrumentation and reagents.
  • Issues and Trends in the Mexican IVD Market

This analysis is the result of on-the-ground research conducted by research firm McEvoy and Farmer interviewing lab managers, product managers and key executives involved with the clinical diagnostics market in Mexico. This analysis was conducted in August – October 2009, and is available to Kalorama Information’s customers as a syndicated research project now.

Mexico Clinical Diagnostics Market

Published: March 2012
No. of Pages: 160

Request Sample

That Mexico is an important market for diagnostic companies and distributors is evident from the amount of players that have entered. Just a few in recent years: 19 Significant diagnostic companies (profiled in this report) are actively participating in the Mexican market, Siemens completed its Bayer/Dade Behring/DPC changeover in Mexico, Beckman controls the Olympus organization in Mexico, Qiagen increased its presence in the country, Genzyme continues to use the DCL name in Mexico, China’s most successful diagnostic exporter, Mindray, is now competing in Mexico. Preparation for flu has given a significant boost to the local molecular testing market among several international and local companies who have testing solutions for it.

Information is difficult to obtain. Due to a partnership between Kalorama Information and McEvoy and Farmer, we are able to offer a copy of their well-known multi-client study for our syndicated research customers. Written by McEvoy and Farmer, experts who have long been known for the best on-the-ground market research in world diagnostics, Clinical Diagnostics in Mexico: Market Analysis and Participant Directory is the most comprehensive research available on Mexico’s growing IVD marketplace.

Table Of Contents

CHAPTER ONE: COUNTRY SUMMARY

Market Totals
What is new in Mexico?
Population
The Economy
The Health Sector
Segmentation
Public Sector Purchasing
Laboratories
Product Registration
Growth

CHAPTER TWO: SECTOR ANALYSIS: CHEMISTRY

Market Total, Chemistry
Instrument Market Shares
Reagent Market Shares
Chemistry Autoanalyzers
Chemistry Distribution
Market Total, Critical Care
Market Total, Urinalysis

CHAPTER THREE: SECTOR ANALYSIS: HEMATOLOGY AND COAGULATION

Market Total, Hematology
Instrument Market Shares
Reagent Market Shares
Automated Hematology Instrumentation
Hematology Distribution
Market Total: Flow Cytometry
Market Total, Coagulation

CHAPTER FOUR: IMMUNOCHEMISTRY AND MOLECULAR TESTING

Market Total, Immunochemistry
Instrument Market Shares
Reagent Market Shares
Non-Isotopic Immunochemistry Analytes
Blood Screening
Infectious Disease Testing
Hormone Testing
Cancer Testing
Specific Protein Testing
Drug Testing
Autoimmune Testing
Allergy Testing
Rapid Tests
Hemoglobin Fraction Analysis (HbA1c)
Prenatal and Neonatal Testing
Non-Isotopic Immunochemistry Instrumentation
Immunochemistry Distribution; Manufacturers with an office in Mexico
Market Total, Molecular Testing
Molecular Testing
Molecular Laboratories
Leading Molecular Analytes
Viral Load Testing
HPV Testing
Influenza A sub-types including H1N1
HLA Typing
Molecular Blood Screening
Molecular Cancer Testing
Micro arrays
Average Unit Prices
Molecular Growth Rate
Molecular Market Shares
Molecular Testing Instrumentation

CHAPTER FIVE: IVD COMPANIES

Abbott Laboratories
Adaltis
Applied Biosystems (Life Technologies)
Beckman Coulter
AND OTHER IVD COMPANIES

CHAPTER SIX: DISTRIBUTORS

Accesorios para Laboratorios (Accesolab)
Accutrack
Atyde
BCR International
Biodist / Amplibio
AND OTHER DISTRIBUTORS

List Of Tables

Filed in: In Vitro Diagnostic
More Reports
Title Price Buy Now

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......
$4950

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......
$7500

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......
$7500

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......
$10995

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......
$7500

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......
$7500

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......
$7500

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......
$7500

Cytomegalovirus  (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

"Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......
$7500

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......
$7500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy